Parnian Arjmand MD

Participates in 4 items

Financial disclosure: Dr. Arjmand has/had an affiliation (financial or otherwise) with a commercial organization.

  1. Roche
  2. Bayer
  3. Apobiologix

Sessions in which Parnian Arjmand MD participates

Saturday 27 June, 2020

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
14:20
Geographic Atrophy in the Canadian Treat and Extent Trial with Ranibizumab in patients with nAMD
14:20 - 14:30 | 10 minutes

Friday 20 June, 2025

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
15:10
Aflibercept 8 mg versus 2 mg: Intraocular Pressure Changes in Patients with Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema - 5456
Vancouver Convention Centre (East Building) - Ballroom B
15:12 - 15:17 | 5 minutes

Author’s Name(s): Parnian Arjmand, Ramin Khoramnia, Paolo Lanzetta, Anat Loewenstein, Michael Stewart, Richard Gale, Marion Munk, Ursula Schmidt-Ott, April McCullough, Claudia Tueckmantel, Alyson BerlinerAuthor’s Disclosure Block: Parnian Arjmand: Hoffman La Roche, Employment/honoraria/consulting fees, Bayer, Employment/honoraria/consulting fees, Apobiologix, Employment/honoraria/consulting fees, Young MDConnect, Employment/honoraria/consulting fees; R...

15:15
Q&A
Vancouver Convention Centre (East Building) - Ballroom B
15:17 - 15:20 | 3 minutes

Saturday 21 June, 2025

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
7:00
Changing the Game Plan - Addressing the Growing Challenge of Clinic Capacity in Retinal Care
Vancouver Convention Centre (East Building) - Meeting Room 1/2/3
7:00 - 8:30 | 1 hour 30 minutes
Co-Developed Symposium

Join us at this Accredited Symposium co-developed with COS and Roche!Chaired by Bernard Hurley and Cynthia Qian.The retinal care symposium is also taking shape. Drawing inspiration from "Who Wants to Be a Millionaire," we are developing an engaging game-show format where specialists tackle increasingly challenging clinical ...